You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫藥(03320.HK):華潤三九2023年淨利潤預計28.18億至30.65億元

格隆匯1月25日丨華潤醫藥(03320.HK)發佈公吿,2024年1月24日,華潤三九(000999.SZ)公佈其截至2023年12月31日止年度業績預吿,據此,其公吿截至2023年12月31日止年度歸屬於華潤三九股東的淨利潤預計約人民幣28.18億元至人民幣30.65億元(上年同期:淨盈利約人民幣24.49億元)、扣除非經常性損益後的歸屬於華潤三九股東的淨利潤預計約人民幣26.78億元至人民幣28.88億元(上年同期:淨盈利約人民幣22.19億元)、基本每股收益預計約人民幣2.87元╱股至約人民幣3.12元╱股(上年同期:盈利約人民幣2.48元╱股)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account